Cardozo JMNL, Byng D, Drukker CA, Schmidt MK, et al. Outcome without any adjuvant systemic treatment in stage I ER+/HER2- breast cancer patients included in the MINDACT trial. Ann Oncol 2021 Nov 30. pii: S0923-7534(21)04829.
PMID: 34861376